Araştırma Makalesi

COVID-19 hastalarında anjiyotensin 2 (ACE2) genin ekspresyon seviyesi

Cilt: 46 Sayı: 4 30 Aralık 2021
PDF İndir
EN TR

Expression level of the angiotensin 2 (ACE2) gene in patients with COVID-19

Abstract

Purpose: Coronavirus disease -19 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV2). The angiotensin converting enzyme 2 (ACE2) can play a vital role in regulating the pathological changes of various diseases, including COVID-19. The aim of this study was to analyze the expression of the ACE2 gene in Turkish COVID-19 patients. Materials and Methods: Eighty COVID-19 PCR test positive patients and 80 PCR test negative healthy volunteers were included in the study. RNA isolation was carried out from all samples. The RT-PCR device was used to analyze the expression of the ACE2 gene. Results: A significant difference was found in the age, Lactate dehydrogenase (LDH), ferritin and C-reactive protein (CRP) levels of the COVID-19 patients compared to the healthy volunteers. Based on the gene expression results, it was found that ACE2 gene expression was significantly higher in COVID-19 patients compared to healthy volunteers. In patients with COVID-19, a significant difference was found between the expression of the ACE2 gene and the levels of Blood urea nitrogen (BUN), Hemoglobin (HGB), Hematocrit (HCT) and CRP. Conclusion: ACE2 gene expression was high in the COVID-19 patients and showed differences based on clinical data. Thus, the expression of ACE2 can have paradoxical effects that support the pathogenicity of SARSCoV2 but, conversely, limit viral infection. The availability of ACE2 receptors may increase the susceptibility and / or disease course of COVID-19.

Keywords

COVID-19 , ACE-2 , Lactate dehydrogenase , CRP , BUN , Hemoglobin

Kaynakça

  1. 1. Gül Ü. COVID-19 and dermatology. TURKISH J Med Sci. 2020;50(8):1751–9.
  2. 2. Scialo F, Daniele A, Amato F, et al. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198(6):867–77.
  3. 3. Wiese O, Zemlin AE, Pillay TS. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2). J Clin Pathol. 2021;74(5):285–90.
  4. 4. Yamamoto K, Takeshita H, Rakugi H. ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19. Clin Sci. 2020;134(22):3047–62.
  5. 5. Beacon TH, Delcuve GP, Davie JR. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus 1. Genome. 2021;64(4):386–99.
  6. 6. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
  7. 7. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8.
  8. 8. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80- ). 2020;367(6485):1444–8.
  9. 9. Kowalczuk S, Bröer A, Tietze N, Vanslambrouck JM, Rasko JEJ, Bröer S. A protein complex in the brush‐border membrane explains a Hartnup disorder allele. FASEB J. 2008;22(8):2880–7.
  10. 10. Lin Q, Keller RS, Weaver B, Zisman LS. Interaction of ACE2 and integrin β1 in failing human heart. Biochim Biophys Acta - Mol Basis Dis. 2004;1689(3):175–8.

Kaynak Göster

MLA
Dirican, Ebubekir, vd. “COVID-19 hastalarında anjiyotensin 2 (ACE2) genin ekspresyon seviyesi”. Cukurova Medical Journal, c. 46, sy 4, Aralık 2021, ss. 1508-15, doi:10.17826/cumj.982658.